Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

GlaxoSmithKline, ViiV identify new HIV allosteric integrase inhibitors

Sep. 5, 2017

ViiV Healthcare divulges new HIV maturation inhibitors

Aug. 24, 2017

GlaxoSmithKline identifies novel ingenol derivatives

Aug. 16, 2017

EMERALD study bolsters darunavir, cobicistat, emtricitabine and tenofovir alafenamide fumarate

Aug. 11, 2017

FDA grants priority review to NDA for bictegravir/emtricitabine/tenofovir alafenamide in HIV

Aug. 11, 2017

Mologen announces results from extension phase of TEACH study of lefitolimod in HIV

Aug. 10, 2017

GlaxoSmithKline patents HIV maturation inhibitors

Aug. 9, 2017

Mylan receives PEPFAR tentative approval for TLD fixed-dose combination regimen

Aug. 8, 2017

Janssen reports results of APPROACH study of Ad26.Mos.HIV HIV-1 vaccine regimens

Aug. 8, 2017

The PS externalization pathway as a potential new target for the development of anti-HIV-1 therapies

Aug. 7, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...